Extended-Spectrum β-lactamases and AmpC Production among Uropathogenic Isolates of Escherichia coli and Antibiogram Pattern
Emergence of drug resistance in Escherichia coli due to various mechanisms makes the treatment choices very limited. The objective of this research was to investigate extended-spectrum beta-lactamases (ESBLs) and AmpC lactamases in E. coli isolates from urinary tract infections (UTIs) and to assess their antibacterial susceptibility patterns in a health-care context. Atotal of 70 E. coli isolates from clinically assumed cases of UTI patients during the 9months period. The isolates with bacteriuria (105 CFU/ml) were identified. ESBL and AmpC were detected phenotypically. Out of the 70 isolates of uropathogenic E. coli, ESBL production was detected in 34(48.6%) isolates and AmpC producer in 27(38.6%) of isolates in which 14(20%) of them showed coexistence phenotype of both ESBLs and AmpC and 23(32.9%) E. coli isolates were both ESBL and AmpC non-producer. The findings donated information regarding drug resistance. The level of resistance recorded in ESBL-and AmpC-producing uropathogenic E. coli of this study was raising; therefore, it is crucial to have a strict infection control measures and routine monitoring of ESBL-and AmpC-producing bacteria in clinical laboratory.
Alqasim, A., Abu Jaffal, A. and Alyousef, A.A., 2018. Prevalence of multidrug resistance and extended-spectrum β-lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. International Journal of Microbiology, 2018, p.3026851.
Alyamani, E.J., Khiyami, A.M., Booq, R.Y., Majrashi, M.A., Bahwerth, F.S. and Rechkina, E., 2017. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Annals of Clinical Microbiology and Antimicrobials, 16, p.1.
Al-Zarouni, M., Senok, A., Rashid, F., Al-Jesmi, S.M. and Panigrahi, D., 2008. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Medical Principles and Practice, 17, pp.32-36.
Arsalane, L., Zerouali, K., Katfy, K. and Zouhair, S., 2015. Molecular characterization of extended spectrum β-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. African Journal of Urology, 21, pp.161-166.
Bakshi, R., Sehgal, V.K., Kansal, P. and Kaur, S., 2019. Detection of extended-spectrum beta lactamases and AmpC beta lactamases producing uropathogenic Escherichia coli in a tertiary care hospital. 8, p.23503.
Bandekar, N., Vinodkumar, C., Basavarajappa, K., Prabhakar, P. and Nagaraj, P., 2011. Beta lactamases mediated resistance amongst gram negative bacilli in burn infection. International Journal of Biological and Medical Research, 2, pp.766-770.
Barua, T., Shariff, M. and Thukral, S., 2013. Detection and characterization of AmpC Β-lactamases in Indian clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca. Universal Journal of Microbiology Research, 1, pp.15-21.
Bush, K., Jacoby, G.A. and Medeiros, A.A., 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy, 39, p.1211.
Coudron, P.E., Moland, E.S. and Thomson, K.S., 2000. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. Journal of Clinical Microbiology, 38, pp.1791-1796.
Fam, N., Gamal, D., El Said, M., Aboul-Fadl, L., El Dabei, E., El Attar, S., Sorur, A., Fouad, S. and Klena, J., 2013. Detection of plasmid-mediated AmpC beta-lactamases in clinically significant bacterial isolates in a research institute hospital in Egypt. Life Science Journal, 10, pp.2294-2304.
Foad, M.F., 2016. Phenotypic detection and antimicrobial susceptibility profile of ESBL, AmpC and carbapenemase producing gram-negative isolates from outpatient clinic specimens. International Journal of Current Microbiology and Applied Sciences, 5, pp.740-752.
Giwa, F.J., Ige, O.T., Haruna, D.M., Yaqub, Y., Lamido, T.Z. and Usman, S.Y., 2018. Extended-spectrum beta-lactamase production and antimicrobial susceptibility pattern of uropathogens in a tertiary hospital in Northwestern Nigeria. Annals of Tropical Pathology, 9, p.11.
Gupta, V., Rani, H., Singla, N., Kaistha, N. and Chander, J., 2013. Determination of extended-spectrum β-lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to fosfomycin. Journal of Laboratory Physicians, 5, p.90.
Hoseini, N., Sedighi, I., Nejad, A.S.M. and Alikhani, M.Y., 2017. Phenotypic and genotypic detection of AmpC enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae. Journal of Krishna Institute of Medical Sciences, 6, pp.10-18.
Humphries, R.M., Ambler, J., Mitchell, S.L., Castanheira, M., Dingle, T., Hindler, J.A., Koeth, L. and Sei, K., 2018. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. Journal of Clinical Microbiology, 56, pp.e01934-17.
Ibrahimagić, A., 2016. Prevalence and antimicrobial resistance of betalactamase-producing gram-negative isolates from outpatient clinical and environmental samples in the Zenica-Doboj Canton, Bosnia and Herzegovina. Journal of Health Sciences, 6, p.337.
Iroha, I., Okoye, E., Osigwe, C., Moses, I., Ejikeugwu, C. and Nwakaeze, A., 2017. Isolation, phenotypic characterization and prevalence of ESBL-producing Escherichia coli and Klebsiella species from orthopedic wounds in National Orthopedic Hospital Enugu (NOHE), South East Nigeria. Journal of Pharmaceutical Care and Health Systems, 4, pp.1-5.
Kaur, S., Gupta, V. and Chhina, D., 2016. AmpC β-lactamases producing gram-negative clinical isolates from a tertiary care hospital. Journal of Mahatma Gandhi Institute of Medical Sciences, 21, pp.107-110.
Kayastha, K., Dhungel, B., Karki, S., Adhikari, B., Banjara, M.R., Rijal, K.R. and Ghimire, P., 2020. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting international friendship children’s hospital, Kathmandu, Nepal. Infectious Diseases: Research and Treatment, 13, p.1178633720909798.
Kazemian, H., Heidari, H., Ghanavati, R., Ghafourian, S., Yazdani, F., Sadeghifard, N., Valadbeigi, H., Maleki, A. and Pakzad, I., 2019. Phenotypic and genotypic characterization of ESBL-, AmpC-, and carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates. Medical Principles and Practice, 28, pp.547-551.
Kizilay, F., Aliyev, B., Şimşir, A., Kalemci, M.S., Köse, T., Taşbakan, M. and Pullukçu, H., 2020. Carbapenem-resistant Klebsiella pneumonia infection outbreak in a tertiary urology clinic: Analysis of influencing factors with a controlled trial. Turkish Journal of Medical Sciences, 50, pp.239-247.
Koshesh, M., Mansouri, S., Hashemizadeh, Z. and Kalantar-Neyestanaki, D., 2016. Identification of extended-spectrum β-lactamase genes and ampc-β- lactamase in clinical isolates of Escherichia coli recovered from patients with urinary tract infections in Kerman, Iran. Archives of Pediatric Infectious Diseases, 5, p.e37968.
Laxman, C.V. and Ashok, P.A., 2016. Profile and antimicrobial susceptibility pattern of urinary bacterial isolates at a tertiary care hospital in central India. European Journal of Biomedical, 3, pp.560-564.
Lee, C.H., Lee, Y.T., Kung, C.H., Ku, W.W., Kuo, S.C., Chen, T.L. and Fung, C.P., 2015. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae. Journal of Microbiology, Immunology and Infection, 48, pp.269-275.
Madhumati, B., Rani, L., Ranjini, C. and Rajendran, R., 2015. Prevalence of AMPC beta lactamases among gram negative bacterial isolates in a tertiary care hospitals. International Journal of Current Microbiology and Applied Sciences, 4, pp.219-227.
Mandal, D.K., Sah, S.K., Mishra, S.K., Sharma, S., Kattel, H.P., Pandit, S., Yadav, P.K., Laghu, U., Lama, R. and Sah, N.P., 2020. Carriage of extended-spectrum-β-lactamase-and AmpC-β-lactamase-producing Enterobacteriaceae (ESBL-PE) in healthy community and outpatient department (OPD) patients in Nepal. Canadian Journal of Infectious Diseases and Medical Microbiology, 2020, p.5154217.
Moroh, J.L., Fleury, Y., Tia, H., Bahi, C., Lietard, C., Coroller, L., Edoh, V., Coulibaly, A., Labia, R. and Leguerinel, I., 2014. Diversity and antibiotic resistance of uropathogenic bacteria from Abidjan. African Journal of Urology, 20, pp.18-24.
Nasir, K.M., Preeti, S., Vikili, C. and Singh, N.P., 2015. Prevalence of ESBL and AmpC βlactamase in gram negative bacilli in various clinical samples at tertiary care hospital. International Research Journal of Medical Sciences, 3, p.1-6.
Nayar, R., Arora, V.M. and Duggal, S., 2012. Antibiotic impregnated tablets for screening ESBL and AmpC beta lactamases. The IOSR Journal of Pharmacy, 2, 207-209.
Osthoff, M., Mcguinness, S.L., Wagen, A.Z. and Eisen, D.P., 2015. Urinary tract infections due to extended-spectrum beta-lactamase-producing gram-negative bacteria: Identification of risk factors and outcome predictors in an Australian tertiary referral hospital. International Journal of Infectious Diseases, 34, pp.79-83.
Rahamathulla, M.P. and Harish, B.N., 2016. Molecular characterization of ESBL and AmpC β-lactamases among blood isolates of Klebsiella pneumoniae andEscherichia coli. Microbiology Research Journal International, 12, pp.1-19.
Rani, S., Rao, K., Ravinder, S. and Kanakadurga, P., 2016. Prevalence of extended spectrum beta lactamases (ESBL) producing Pseudomonas aeruginosa isolates from burn patients. Proceedings of the International Journal of Contemporary Medical Research, 5, pp.1297-1300.
Rodríguez-Guerrero, E., Callejas-Rodelas, J.C., Navarro-Marí, J.M. and Gutiérrez-Fernández, J., 2022. systematic review of plasmid AmpC type resistances in Escherichia coli and Klebsiella pneumoniae and preliminary proposal of a simplified screening method for ampC. Microorganisms, 10, p.611.
Rowe, T.A. and Juthani-Mehta, M., 2013. Urinary tract infection in older adults. Aging Health, 9, pp.519-528.
Senbayrak, S., Boz, E.S., Cevan, S., Inan, A., Engin, D.O., Dosoglu, N., Cobanoglu, N., Dagli, O., Davarci, I. and Aksaray, S., 2017. Antibiotic resistance trends and the ESBL prevalence of Escherichia coli and Klebsiella spp. urinary isolates in in-and outpatients in a tertiary care hospital in İstanbul, 2004-2012. Jundishapur Journal of Microbiology, 10, p.e13098.
Seyedjavadi, S.S., Goudarzi, M. and Sabzehali, F., 2016. Relation between blaTEM, blaSHV and blaCTX-M genes and acute urinary tract infections. Journal of Acute Disease, 5, pp.71-76.
Sheemar, S., Chopra, S., Mahajan, G., Kaur, J. and Chouhan, Y.S., 2016. Extended spectrum beta-lactamase and AmpC producing Klebsiella pneumoniae: A therapeutic challenge. Tropical Journal of Medical Research, 19, p.114.
Šišková, P., Černohorská, L., Mahelová, M., Turková, K. and Woznicová, V., 2015. Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains. Journal of Microbiology, Immunology and Infection, 48, pp.329-334.
Thenmozhi, S., Moorthy, K., Sureshkumar, B. and Suresh, M., 2014. Antibiotic resistance mechanism of ESBL producing Enterobacteriaceae in clinical field: A review. International Journal of Pure and Applied Bioscience, 2, pp.207-26.
Tillekeratne, L.G., Vidanagama, D., Tippalagama, R., Lewkebandara, R., Joyce, M., Nicholson, B.P., Nagahawatte, A., Bodinayake, C.K., De Silva, A.D. and Woods, C.W., 2016. Extended-spectrum ß-lactamase-producing Enterobacteriaceae as a common cause of urinary tract infections in Sri Lanka. Infection and Chemotherapy, 48, pp.160-165.
Yadav, K. and Prakash, S. 2017. Screening of ESBL producing multidrug resistant E. coli from urinary tract infection suspected cases in Southern Terai of Nepal. Journal of Infectious Diseases and Diagnosis, 2, p.2.
Copyright (c) 2022 Aryan R. Ganjo
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-SA 4.0] that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).